Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,642.00
+40.00 (0.71%)
Jul 24, 2026, 3:30 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 673.48 billion as of July 24, 2026. Its market cap has increased by 13.22% in one year.
Market Cap
673.48B
Enterprise Value
649.32B
Revenue
147.12B
Ranking
n/a
PE Ratio
29.26
Stock Price
5,642.00
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 673.48B, an increase of 307.67%. That is a compound annual growth rate of 14.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 673.48B | 2.29% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.14T |
| Zydus Lifesciences | 1.12T |
| Mankind Pharma | 1.05T |
| Aurobindo Pharma | 876.53B |
| Laurus Labs | 851.79B |
| Glenmark Pharmaceuticals | 622.28B |
| Ipca Laboratories | 453.75B |
| Ajanta Pharma | 431.97B |